3-substituted oxindole β-3 agonists

Details 3-substituted oxindole β-3 agonists 3-substituted oxindole β-3 agonists

2005-06-28

2005-06-28

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S254090, C514S278000, C514S323000, C514S381000, C514S383000, C544S230000, C544S333000, C546S015000, C546S198000, C546S277700, C548S146000, C548S147000, C548S181000, C548S250000, C548S266400, C548S407000, C548S411000, C548S508000

Reexamination Certificate

active

06911463

ABSTRACT:
The present invention relates to a β3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.

REFERENCES:
patent: 4276304 (1981-06-01), Ikezaki et al.
patent: 4826847 (1989-05-01), Michel et al.
patent: 5808080 (1998-09-01), Bell et al.
patent: 5977154 (1999-11-01), Bell et al.
patent: 6011048 (2000-01-01), Mathvink et al.
patent: 6825220 (2004-11-01), Jesudason et al.
patent: 2830884 (1979-01-01), None
patent: 166331 (1986-01-01), None
patent: 221414 (1987-05-01), None
patent: 236624 (1987-09-01), None
patent: 611003 (1994-08-01), None
patent: 678511 (1995-10-01), None
patent: 764640 (1997-03-01), None
patent: 827746 (1998-03-01), None
patent: 1549945 (1979-08-01), None
patent: WO 95/29159 (1995-11-01), None
patent: WO 97/10825 (1997-03-01), None
patent: WO 97/46556 (1997-12-01), None
patent: WO 98/4526 (1998-02-01), None
patent: WO 98/9625 (1998-03-01), None
patent: WO 98/32753 (1998-07-01), None
patent: WO 00/40560 (2000-07-01), None
patent: WO 00/44721 (2000-08-01), None
patent: WO 01/7026 (2001-02-01), None
patent: WO 01/35947 (2001-05-01), None
patent: WO 01/36412 (2001-05-01), None
patent: WO 01/53298 (2001-07-01), None
patent: WO 02/6276 (2002-01-01), None
patent: WO 02/38543 (2002-05-01), None
Lee, et al.,J.Het.Chem., 32(1):1-11, 1995.
Mathvink,Bioorganic&Medicinal Chemistry Letters, 9(13):1869-1874, 1999.
Shuker A J, et al;Tetrahedron Letters; 38(35):6149-6152, 1997.
Weber, et al;Bioorganic&Medicinal Chemistry Letters; 8(9):1101-1106, 1998.
Weber, et al;Bioorganic&Medicinal Chemistry Letters; 8(16):2111-2116, 1998.

Affiliated with

Also associated with

Rating

3-substituted oxindole β-3 agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-substituted oxindole β-3 agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted oxindole β-3 agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3475279